Breast cancer screening and diagnosis
TB Bevers, BO Anderson, E Bonaccio, S Buys… - Journal of the National …, 2009 - jnccn.org
Women in the United States have a 12.3% estimated lifetime risk for developing breast
cancer (ie, 1 in 8 women). 1 In 2009, an estimated 194,290 cases of invasive breast cancer …
cancer (ie, 1 in 8 women). 1 In 2009, an estimated 194,290 cases of invasive breast cancer …
Lobular carcinoma in situ
HY Wen, E Brogi - Surgical pathology clinics, 2018 - Elsevier
Lobular carcinoma in situ (LCIS) is a risk factor and a nonobligate precursor of breast
carcinoma. The relative risk of invasive carcinoma after classic LCIS diagnosis is …
carcinoma. The relative risk of invasive carcinoma after classic LCIS diagnosis is …
Breast cancer screening and diagnosis, version 3.2018, NCCN clinical practice guidelines in oncology
TB Bevers, M Helvie, E Bonaccio, KE Calhoun… - Journal of the National …, 2018 - jnccn.org
The NCCN Guidelines for Breast Cancer Screening and Diagnosis have been developed to
facilitate clinical decision making. This manuscript discusses the diagnostic evaluation of …
facilitate clinical decision making. This manuscript discusses the diagnostic evaluation of …
Lobular breast cancer: Clinical, molecular and morphological characteristics
M Christgen, D Steinemann, E Kühnle, F Länger… - … -Research and Practice, 2016 - Elsevier
Infiltrating lobular breast cancer (ILBC) is the most common special breast cancer subtype.
This review provides a comprehensive description of ILBC characteristics, including …
This review provides a comprehensive description of ILBC characteristics, including …
Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision
MP Murray, C Luedtke, L Liberman, T Nehhozina… - Cancer, 2013 - Wiley Online Library
BACKGROUND: No consensus exists on the need to excise breast lesions that yield classic
lobular carcinoma in situ (LCIS) or atypical lobular hyperplasia (ALH)(known together as …
lobular carcinoma in situ (LCIS) or atypical lobular hyperplasia (ALH)(known together as …
High risk (B3) breast lesions: what is the incidence of malignancy for individual lesion subtypes? A systematic review and meta-analysis
Introduction Provide evidence to support evolving management strategies for high-risk (B3)
breast lesions by assessing risk of carcinoma in subgroups of B3 lesions using systematic …
breast lesions by assessing risk of carcinoma in subgroups of B3 lesions using systematic …
Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy
Background The surgical management of lobular in-situ neoplasia (LN) identified by core
needle biopsy (CNB) is currently variable. Our institution has routinely excised LN on CNB …
needle biopsy (CNB) is currently variable. Our institution has routinely excised LN on CNB …
[HTML][HTML] Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review
KL Mooney, LW Bassett, SK Apple - Modern Pathology, 2016 - Elsevier
Optimal management of high-risk breast lesions detected by mammogram yielding atypical
ductal hyperplasia, flat epithelial atypia, atypical lobular hyperplasia, lobular carcinoma in …
ductal hyperplasia, flat epithelial atypia, atypical lobular hyperplasia, lobular carcinoma in …
Incidence of adjacent synchronous invasive carcinoma and/or ductal carcinoma in-situ in patients with lobular neoplasia on core biopsy: results from a prospective …
F Nakhlis, L Gilmore, R Gelman, I Bedrosian… - Annals of surgical …, 2016 - Springer
Background Lobular neoplasia (LN) represents a spectrum of atypical proliferative lesions,
including atypical lobular hyperplasia and lobular carcinoma-in-situ. The need for excision …
including atypical lobular hyperplasia and lobular carcinoma-in-situ. The need for excision …
Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy
MG Shah-Khan, XJ Geiger, C Reynolds… - Annals of surgical …, 2012 - Springer
Background Lobular neoplasia (LN) includes atypical lobular hyperplasia (ALH) and lobular
carcinoma in situ (LCIS). LN often is an incidental finding on breast core needle biopsy …
carcinoma in situ (LCIS). LN often is an incidental finding on breast core needle biopsy …